NCT00832754

Brief Summary

Effective use of Rapid Diagnostic Test (RDT) and artemisinin-based combination therapy (ACT) depends on the accuracy and safety of RDT based treatment practices and on factors related to the health delivery system. We propose to study the accuracy and safety of RDT based diagnosis and treatment of febrile illness, health system determinants of effective use of RDTs and the public health outcomes of RDT based ACT for malaria.A cluster randomised trial of RDT based versus clinical judgment based treatment of febrile illness on the incidence of malaria in \<48 month old children will be conducted. Health Centres will be randomly allocated to RDT based treatment or clinical judgment based treatment arm and children under 2years of age from the catchment area of each health centre will be followed for 2 years. The cost effectiveness of RDT based approach will be compare with the clinical judgement based treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,063

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Mar 2009

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 30, 2009

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2009

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 21, 2012

Status Verified

December 1, 2012

Enrollment Period

3.4 years

First QC Date

January 29, 2009

Last Update Submit

December 20, 2012

Conditions

Keywords

malariarapid diagnostic testartemisininGhana

Outcome Measures

Primary Outcomes (1)

  • Incidence of malaria (fever + any level of parasite density) in < 48 month-old children (Stage 2, Component A)

    Three years

Secondary Outcomes (1)

  • Incidence of severe anaemia (Hb <8 g/dl) in < 48 month old children

    Three years

Study Arms (2)

RDT+ACT group

EXPERIMENTAL

RDT+ACT group (ACT offered to RDT positive cases only)

Device: RDTOther: Clinical Judgement as basis for treatment of malaria with ACT

Clinical judgement+ACT group

ACTIVE COMPARATOR

Clinical judgement+ACT group (ACT offered to all suspected cases of malaria by clinical judgement)

Device: RDTOther: Clinical Judgement as basis for treatment of malaria with ACT

Interventions

RDTDEVICE

Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.

Clinical judgement+ACT groupRDT+ACT group

Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.

Clinical judgement+ACT groupRDT+ACT group

Eligibility Criteria

AgeUp to 48 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All children aged less than 48mths reporting to health center with suspected malaria

You may not qualify if:

  • Children having chronic illnesses such as severe malnutrition and heart disease will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kintampo Health Research Center

Kintampo, BAR, 200, Ghana

Location

Related Publications (3)

  • Tawiah T, Hansen KS, Baiden F, Bruce J, Tivura M, Delimini R, Amengo-Etego S, Chandramohan D, Owusu-Agyei S, Webster J. Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana. PLoS One. 2016 Oct 3;11(10):e0164055. doi: 10.1371/journal.pone.0164055. eCollection 2016.

  • Baiden F, Bruce J, Webster J, Tivura M, Delmini R, Amengo-Etego S, Owusu-Agyei S, Chandramohan D. Effect of Test-Based versus Presumptive Treatment of Malaria in Under-Five Children in Rural Ghana--A Cluster-Randomised Trial. PLoS One. 2016 Apr 7;11(4):e0152960. doi: 10.1371/journal.pone.0152960. eCollection 2016.

  • Baiden F, Webster J, Tivura M, Delimini R, Berko Y, Amenga-Etego S, Agyeman-Budu A, Karikari AB, Bruce J, Owusu-Agyei S, Chandramohan D. Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana. PLoS One. 2012;7(4):e34073. doi: 10.1371/journal.pone.0034073. Epub 2012 Apr 13.

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Frank E Baiden

    Kintampo Health Research Center

    PRINCIPAL INVESTIGATOR
  • Jayne Webster

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Christopher Whitty

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Seth Owusu-Agyei

    Kintampo Health Research Center

    PRINCIPAL INVESTIGATOR
  • Daniel Chandramohan

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Jane Bruce

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 29, 2009

First Posted

January 30, 2009

Study Start

March 1, 2009

Primary Completion

August 1, 2012

Study Completion

December 1, 2012

Last Updated

December 21, 2012

Record last verified: 2012-12

Locations